Opportunities to Improve Cervical Cancer Screening in the United States

Cervical cancer screening is considered a public health success story in the United States. In contrast to developing countries where cervical cancer is a leading cause of mortality and morbidity, the widespread adoption of Pap smear screening since the 1960s in the United States has led to an estimated 50 percent reduction in the incidence of cervical cancer. Yet with still 12,000 new cases of and 4,000 deaths from cervical cancer each year (American Cancer Society 2010), the U.S. screening program is far from perfect.

Author(s): Jane J. Kim

Read on Wiley

Volume 90, Issue 1 (pages 38–41)
DOI: 10.1111/j.1468-0009.2011.00653.x
Published in 2012